# Klemens Budde

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/klemens-budde/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,694 |
| Field | Renal Transplantation Outcomes and Treatments |
| h-index | 89 |
| i10-index | 481 |
| Last Known Institution | Humboldt-Universität zu Berlin |
| OpenAlex ID | https://openalex.org/A5060425510 |
| ORCID iD | 0000-0002-7929-5942 |
| Works | 975 |

## Researcher papers

Showing 12 of 15.

- [Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference](https://scholariq.org/papers/tuberous-sclerosis-complex-diagnostic-criteria-update-recommendations-of-the/)
- [Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/everolimus-for-angiomyolipoma-associated-with-tuberous-sclerosis-complex-or/)
- [Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference](https://scholariq.org/papers/tuberous-sclerosis-complex-surveillance-and-management-recommendations-of-the/)
- [Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection](https://scholariq.org/papers/angiotensin-ii-type-1-receptor-activating-antibodies-in-renal-allograft/)
- [Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations](https://scholariq.org/papers/updated-international-tuberous-sclerosis-complex-diagnostic-criteria-and/)
- [Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report](https://scholariq.org/papers/therapeutic-drug-monitoring-of-tacrolimus-personalized-therapy-second-consensus/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus](https://scholariq.org/papers/results-of-an-international-randomized-trial-comparing-glucose-metabolism/)
- [Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/everolimus-in-patients-with-autosomal-dominant-polycystic-kidney-disease/)
- [Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions](https://scholariq.org/papers/proceedings-from-an-international-consensus-meeting-on-posttransplantation/)
- [Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry](https://scholariq.org/papers/renal-replacement-therapy-for-autosomal-dominant-polycystic-kidney-disease-adpkd/)
- [Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy](https://scholariq.org/papers/results-from-part-a-of-the-multi-center-double-blind-randomized-placebo/)

## Researcher topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [Humboldt-Universität zu Berlin](https://scholariq.org/institutions/humboldt-universitat-zu-berlin/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.